Literature DB >> 1422240

Prenatal diagnosis and caring.

N C Chescheir1, R C Cefalo.   

Abstract

Although the science of prenatal diagnosis is rapidly expanding, the art of caring for these patients is poorly understood and taught. Prenatal diagnosis programs must acknowledge the psychosocial consequences of electing to undergo prenatal testing, receiving either normal or abnormal test results, and choosing to continue or terminate a pregnancy with an identified fetal defect. There are suggestions from the literature of interventions to assist families under these circumstances (Table 3). Prospective studies of patient adaptation are needed; however, on the basis of the retrospective studies and common sense, a reasonable plan for patient support and care can be established. Prenatal diagnosis programs must demand not only excellent medical knowledge and technical expertise but also compassionate and continued care for the patient, her partner, and family.

Entities:  

Keywords:  Genetics and Reproduction

Mesh:

Year:  1992        PMID: 1422240     DOI: 10.1016/s1049-3867(05)80259-2

Source DB:  PubMed          Journal:  Womens Health Issues        ISSN: 1049-3867


  3 in total

1.  Genetic counseling after abnormal prenatal diagnosis: facilitating coping in families who continue their pregnancies.

Authors:  Jill S Allen; Lynda C Mulhauser
Journal:  J Genet Couns       Date:  1995-12       Impact factor: 2.537

Review 2.  A case-note review of continued pregnancies found to be at a high risk of Huntington's disease: considerations for clinical practice.

Authors:  Felicity Wadrup; Simon Holden; Rhona MacLeod; Zosia Miedzybrodzka; Andrea H Németh; Shan Owens; Sara Pasalodos; Oliver Quarrell; Angus J Clarke
Journal:  Eur J Hum Genet       Date:  2019-03-19       Impact factor: 4.246

3.  Perinatal Palliative Care: A qualitative study evaluating the perspectives of pregnancy counselors.

Authors:  Franziska Flaig; Julia D Lotz; Kathrin Knochel; Gian Domenico Borasio; Monika Führer; Kerstin Hein
Journal:  Palliat Med       Date:  2019-03-07       Impact factor: 4.762

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.